💼InvestingEli Lilly Shares Climb on Positive Clinical Trial Data and Expanded Access
Eli Lilly shares rose following successful phase 3 trial results for its GLP-1 drugs in treating osteoarthritis and sleep apnea. The company also announced a partnership …